Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
34
NCT00411723
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: May 31, 2009